1 month ago

Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

Share this!

Read Entire Article
  1. Homepage
  2. Finance
  3. Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

Related

Mullen Automotive's Bollinger Motors Expands Midwest Reach With Broadway Ford Truck Center Dealership

Mullen Automotive's Bollinger Motors Expands Midwest Reach W...

1 week ago
Why Shell Stock Is Rising

Why Shell Stock Is Rising

1 week ago
Why Bilibili Shares Are Exploding Higher

Why Bilibili Shares Are Exploding Higher

1 week ago

© NewsMage 2024. All rights are reserved

About Us · Contact Us · Follow Us ·